EXP2574_7776.pdf

PUR 7776 (Revised 07/2022) Page 1 of 2 Incorporated by Reference: Rule 60A-1.045, F.A.C.

DESCRIPTION OF INTENDED

SINGLE SOURCE PURCHASE

(PUR 7776)

This description of commodities or contractual services intended for purchase from a single source is posted in accordance with Sections 120.57(3) and 287.057(3), Florida Statutes (F.S.), and will remain posted for a period of at least 15 business days.

Commodity or Contractual Service Required (commodity or United National Standard Products and Services Code (NSPSC), manufacturer, model, and description, as appropriate):

12161500 Indicators and Reagents 41116000 Clinical and diagnostic analyzer reagents 41116100 Manual test kits and quality controls and calibrators and standards

Quantity or Term (as appropriate):

3 years

Requestor (division, bureau, office, individual, as appropriate):

DOH Bureau of Public Health Laboratories (BPHL)

Performance and/or Design Requirements (e.g. intended use, function or application, compatibility, requirements; reference to policy, rule, statute or other act of the Legislature, etc., as appropriate): The DOH BPHL has a need to purchase a system to perform HIV-1/HIV-2 Supplemental differentiation assay testing to confirm HIV infection in patients testing positive on an initial screen. The assay must be able to test whole blood, serum, plasma, and in-house validated oral fluid to conform to the CDC 2014 HIV Diagnostic Algorithm guidelines.

In accordance with Chapter 60A-1.045, Florida Administrative Code, the Florida Department of Health, BPHL, requests authorization to purchase, as a single source, the Bio-Rad Laboratories Geenius™ System assays and controls.

AGENCY: Florida Department of Health (DOH)

TITLE: Bio-Rad Laboratories Geenius™ System Short description of the commodity or service desired: Assays and controls necessary to perform HIV- 1/HIV-2 Supplemental differentiation testing

CONTACT

Name: Chris Lowery Address: 4052 Bald Cypress Way, Tallahassee, FL 32399 Telephone: 850-245-4530 Email: Christina.Lowery@flhealth.gov

Internal tracking number, if any: EXP2574

Date posted: Click or tap to enter a date. Last day for receipt of information: Click or tap to enter a date.

mailto:Christina.Lowery@flhealth.gov

PUR 7776 (Revised 07/2022) Page 2 of 2 Incorporated by Reference: Rule 60A-1.045, F.A.C.

Intended Single Source:

Bio-Rad Laboratories, Inc.

Estimated Dollar Amount:

$460,000.00

Justification for single source acquisition (what is necessary and unique about the product, services or source; steps taken to confirm unavailability of competition, as appropriate):

• The Geenius™ System is the only FDA approved HIV-1/HIV-2 differential assay currently on the U.S. market and has been validated in-house for the confirmation of HIV-1 Oral Fluid meeting the guidelines required.

• Bio-Rad Laboratories (manufacturer) is the sole distributor of the Geenius™ System.

Approved By (names & titles, as appropriate, e.g., requestor, requestor management, information systems, budget, purchasing):

Allegra Small, Purchasing Director

Prospective vendors are requested to provide information regarding their ability to supply the commodities or contractual services described. If it is determined in writing by the agency, after reviewing any information received from prospective vendors, that the commodities or contractual services are available only from a single source, the agency shall provide notice of its intended decision to enter a single-source purchase contract in the manner specified in Rule 60A-1.045, Florida Administrative Code, and section 120.57(3), F.S.